✦ LIBER ✦

Cetuximab plus FOLFIRI in first-line treatment of KRAS mutation-negative, EGFR-positive metastatic colorectal cancer

✍ Scribed by Jame Abraham

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cetuximab plus FOLFIRI as a first-line t

✍ Daniel G. Haller 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 100 KB

O-0029 * FOLFIRI PLUS CETUXIMAB VERSUS F

✍ Modest, D.; von Weikersthal, L. F.; Stintzing, S.; Decker, T.; Kiani, A.; Vehlin 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 33 KB

FOLFIRI plus cetuximab versus FOLFIRI pl

✍ Stintzing, S.; Fischer von Weikersthal, L.; Decker, T.; Vehling-Kaiser, U.; Jage 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 225 KB

3001 ORAL CRYSTAL, a randomized phase II

✍ E. van Cutsem; G. Bodoky; J. Kyung Roh; G. Folprecht; Y.S. Park; J.L. van Laethe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

FOLFIRI plus cetuximab versus FOLFIRI pl

✍ Heinemann, Volker; von Weikersthal, Ludwig Fischer; Decker, Thomas; Kiani, Alexa 📂 Article 📅 2014 🏛 Lancet Publishing Group 🌐 English ⚖ 289 KB

FOLFIRI plus cetuximab versus FOLFIRI pl

✍ Heinemann, Volker; von Weikersthal, Ludwig Fischer; Decker, Thomas; Kiani, Alexa 📂 Article 📅 2014 🏛 Lancet Publishing Group 🌐 English ⚖ 289 KB